Kamel Laribi
Kamel Laribi publishes mostly in Hematology, Genetics and Pathology and Forensic Medicine, on topics such as Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment and Acute Myeloid Leukemia Research.
- World rank
- #746,747 of 7,710,434 ranked researchers
- Rank in France
- #36,671 of 324,115
- Works
- 200
- Citations
- 5.2k
- Citations per work
- 26.2
What does Kamel Laribi research?
Kamel Laribi's work is mostly in Medicine (67%), Biochemistry, Genetics and Molecular Biology (7%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences13466.8%
- Medicine13466.8%
- Everything else3919.5%
- Life Sciences2713.7%
- 1Hematology26% of their works
- 2Genetics20% of their works
- 3Pathology and Forensic Medicine12% of their works
- 4Oncology9% of their works
- 5Molecular Biology7% of their works
- 6Immunology7% of their works
Research topics
- Chronic Lymphocytic Leukemia Research
- Lymphoma Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Protein Degradation and Inhibitors
- Immunodeficiency and Autoimmune Disorders
- Hemoglobinopathies and Related Disorders
Which keywords describe Kamel Laribi's research?
The keywords of their largest research topics: Rituximab, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations, Classification, Lymphoma, Acute Myeloid Leukemia and AML.
- Thalassemia
- Primary Immunodeficiency
- Genetic Mutations
- Myelofibrosis
- International Myeloma Working Group
- Acute Myeloid Leukemia
- Lymphoma
- Genomic Aberrations
- Prognostic Factors
- Rituximab
- Chronic Lymphocytic Leukemia
- Classification
- AML
- Diagnosis Criteria
- JAK2 Mutation
- BET Bromodomains
- PROTACs
- Sickle-cell Disease
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Rituximab1252 topics
- Prognostic Factors1172 topics
- Chronic Lymphocytic Leukemia641 topic
- Genomic Aberrations641 topic
- Classification611 topic
- Lymphoma611 topic
- AML531 topic
- Acute Myeloid Leukemia531 topic
- Diagnosis Criteria381 topic
- International Myeloma Working Group381 topic
- JAK2 Mutation311 topic
- Myelofibrosis311 topic
- BET Bromodomains161 topic
- Genetic Mutations161 topic
- PROTACs161 topic
- Primary Immunodeficiency161 topic
- Sickle-cell Disease131 topic
- Thalassemia131 topic
Where does Kamel Laribi work?
Kamel Laribi's main affiliation in the publication record is Centre Hospitalier du Mans, France.
How many publications and citations does Kamel Laribi have?
OpenAlex counts 200 works and 5,248 citations for Kamel Laribi, an h-index of 34, ranking #746,747 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Kamel Laribi
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kamel Laribi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.